Evaluation of the use of apixaban in prevention of thromboembolic disease in patients with myeloma treated with iMiDs

被引：0
|
作者：
Gavard, M. [1 ]
Pegourie, B. [2 ]
Pernod, G. [3 ]
Rolland-Neyret, V. [2 ]
机构：
[1] CHU Grenoble Alpes, Delegat Rech Clin & Innovat, Grenoble, France
[2] CHU Grenoble Alpes, Serv Hematol, Grenoble, France
[3] CHU Grenoble Alpes, Serv Med Vasc, Grenoble, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM2 - 044
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] INDOBUFEN IN THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH CARDIAC DISEASE
    FORNARO, G
    ROSSI, P
    MANTICA, PG
    CACCIA, ME
    ARALDA, D
    LAVEZZARI, M
    MILANESI, G
    ARTERIOSCLEROSIS, 1990, 10 (05): : A910 - A910
  • [22] INDOBUFEN IN THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH CARDIAC DISEASE
    FORNARO, G
    ROSSI, P
    MANTICA, PG
    CACCIA, ME
    ARALDA, D
    LAVEZZARI, M
    MILANESI, G
    CIRCULATION, 1990, 82 (04) : 602 - 602
  • [23] Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents
    Cornell, Robert F.
    Goldhaber, Samuel Z.
    Engelhardt, Brian G.
    Moslehi, Javid
    Jagasia, Madan
    Harrell, Shelton
    Rubinstein, Samuel M.
    Hall, Robert
    Wyatt, Houston
    Piazza, Gregory
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (04) : 555 - 561
  • [24] Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery
    Glickman, Amanda
    Brennecke, Alyse
    Tayebnejad, Anna
    Matsuo, Koji
    Guntupalli, Saketh R.
    Sheeder, Jeanelle
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : 476 - 482
  • [25] Risk assessment tools of thromboembolic events in multiple myeloma patients treated with immunomodulators
    Le Rigoleur, Astrid
    Beltjens, Magali
    Descamps, Olivier
    Kentos, Alain
    ACTA CLINICA BELGICA, 2021, 76 : 46 - 46
  • [26] APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL
    Cowper, Patricia A.
    Pan, Wenqin
    Anstrom, Kevin
    Stafford, Judith
    Lopes, Renato
    Davidson-Ray, Linda
    Wallentin, Lars
    Phatak, Hemant
    Ansell, Jack
    Dorian, Paul
    Husted, Steen
    McMurray, John
    Steg, P. Gabriel
    Alexander, John
    Granger, Christopher
    Mark, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1576 - E1576
  • [27] Prevention of thromboembolic disease in elderly patients admitted to medical wards
    Lopez-Picazo Ferrer, J. J.
    Vidal-Abarca Gutierrez, I
    Moreno Lopez, A. B.
    JOURNAL OF HEALTHCARE QUALITY RESEARCH, 2020, 35 (04) : 209 - 215
  • [28] What is the best preventive treatment for thromboembolic complications in patients treated with thalidomide for multiple myeloma?
    Macro, Margaret
    HEMATOLOGIE, 2011, 17 (03): : 176 - 177
  • [29] Measurable disease evaluation in patients with myeloma
    Roshal, Mikhail
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (01)
  • [30] USE OF A HEPARINOID IN PATIENTS WITH HEMORRHAGIC STROKE AND THROMBOEMBOLIC DISEASE
    TENCATE, H
    HENNY, CP
    BULLER, HR
    TENCATE, JW
    MAGNANI, HN
    ANNALS OF NEUROLOGY, 1984, 15 (03) : 268 - 270
12345